Henry Schein, Inc. $HSIC Shares Purchased by Graham Capital Management L.P.

Key Points

• Graham Capital Management L.P. increased its stake in Henry Schein, Inc. by 181.7% in Q1, acquiring an additional 26,645 shares, bringing its total holdings to 41,308 shares valued at approximately $2.83 million.
• Various analysts have downgraded their price targets for Henry Schein, with Barrington Research reducing its target from $86 to $78, while UBS lowered theirs from $75 to $70, indicating mixed sentiments about the stock's future.
• Henry Schein's recent earnings report revealed a quarterly EPS of $1.10, missing the analysts' consensus of $1.19, but the company's revenue of $3.24 billion slightly exceeded expectations, showing a 3.3% increase year-over-year.

Graham Capital Management L.P. boosted its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 181.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,308 shares of the company's stock after buying an additional 26,645 shares during the period. Graham Capital Management L.P.'s holdings in Henry Schein were worth $2,829,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ananym Capital Management LP grew its position in Henry Schein by 1.7% in the 1st quarter. Ananym Capital Management LP now owns 479,647 shares of the company's stock valued at $32,851,000 after buying an additional 8,140 shares during the last quarter. Caption Management LLC purchased a new position in Henry Schein in the 1st quarter valued at $470,000. Quarry LP purchased a new position in Henry Schein in the 1st quarter valued at $71,000. Vident Advisory LLC grew its position in Henry Schein by 45.8% in the 1st quarter. Vident Advisory LLC now owns 5,120 shares of the company's stock valued at $351,000 after buying an additional 1,608 shares during the last quarter. Finally, Magnetar Financial LLC purchased a new position in Henry Schein in the 1st quarter valued at $1,809,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on HSIC. Barrington Research decreased their target price on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 6th. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research report on Monday, July 14th. Robert W. Baird restated a "neutral" rating and set a $72.00 target price (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Finally, Wall Street Zen raised shares of Henry Schein from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, Henry Schein presently has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Price Performance

HSIC traded up $0.65 during midday trading on Thursday, reaching $67.78. 1,316,275 shares of the company's stock were exchanged, compared to its average volume of 1,755,706. The business's 50-day moving average price is $70.11 and its 200 day moving average price is $69.91. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The stock has a market capitalization of $8.22 billion, a PE ratio of 21.86, a P/E/G ratio of 2.30 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period in the previous year, the firm posted $1.23 EPS. The company's revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.